Bioavailability of aspirin in the presence of dextropropoxyphene/paracetamol combination

Bioavailability of aspirin in the presence of dextropropoxyphene/paracetamol combination

The effect of 2 doses of a combination analgesic preparation (each dose containing 65 mg dextropropoxyphene hydrochloride and 650 mg paracetamol) upon plasma salicylate concentration after a single dose of soluble aspirin (1.2 g) or enteric-coated aspirin (1.2 g) was examined in 6 normal volunteers...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 2(1981), 8 vom: 16., Seite 543-6
1. Verfasser: Hemming, J D (VerfasserIn)
Weitere Verfasser: Bird, H A, Pickup, M E, Saunders, A, Lowe, J R, Dixon, J S
Format: Aufsatz
Sprache:English
Veröffentlicht: 1981
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Clinical Trial Controlled Clinical Trial Journal Article Randomized Controlled Trial Drug Combinations Acetaminophen 362O9ITL9D acetaminophen, dextropropoxyphene, drug combination 39400-85-6 Aspirin mehr... R16CO5Y76E Dextropropoxyphene S2F83W92TK